Implementation of the Eetscore in patients with inflammatory bowel disease: relevant tool in clinical practice?

Completed

• Conditions: chronic inflammation of the bowel; inflammatory bowel disease; 10017969

• Registration Number: NL-OMON49659
• Lead Sponsor: Stichting Alliantie Voeding in de Zorg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2021-07-13
• Last Update Posted: 11 June 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 212

Inclusion Criteria

- Diagnosis of Crohn's disease, ulcerative colitis or IBD-U made by a
gastroenterologist
- 18 years of age or older
- Ability to read and understand the Dutch language
- The patient has access to an email address and a device to complete the
online questionnaire
- The patient has signed the informed consent form

Exclusion Criteria

- Receiving treatment by a dietician or specific dietary advice (e.g. due to
malnutrition or an eating disorder)
- Allergic to nuts, peanuts, fish or cow's milk protein
- Adherence to a vegan lifestyle
- Participation in another intervention study

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Primary outcomes are total score on the Eetscore and quality of life as<br /><br>measured by the short Inflammatory Bowel Disease Questionnaire (sIBDQ).</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary outcomes are clinical disease activity as measured by the patient<br /><br>Harvey Bradshaw Index (p-HBI) in Crohn*s Disease and the Patient Simple<br /><br>Clinical Colitis Activity Index (P-SCCAI) in ulcerative colitis, and evaluation<br /><br>of the Eetscore.</p><br>